Wellnex Life Limited
WNX.ASXConsumer Staples
The sale and distribution of health and wellness products
Market Data
$0.057
-0.0%$4.4M
-100000.0x
$-0.351
0.00%
-0.7%
Latest Earnings
Appendix 4C and Quarterly Report for Mar 2026 Quarter
30 April 2026
Wellnex Life achieved a significant milestone by returning to positive operating cash flow of $0.41M in Q3 FY26, marking the first profitable quarter since its turnaround strategy commenced. Customer cash receipts surged 30.8% to $6.67M driven by strong commercial momentum across core brands, though reported revenue declined 28.2% to $5.1M due to cyclical IP licensing weakness and reduced marketing investment. The company demonstrated disciplined cost management with staff costs down 29% and is targeting revenue growth and margin improvement in Q4 FY26. Key points: First quarter of positive operating cash flow ($0.41M) since turnaround strategy commenced, validating management's strategic execution; Customer cash receipts surged 30.8% to $6.67M reflecting strong commercial momentum across core brands (Pain Away, Wakey Wakey, Nighty Night) and improved working capital conversion; Structural cost reductions delivering measurable results: staff costs down 29% to $0.75M and advertising/marketing down to $0.54M, demonstrating broad-based operational efficiency
Recent Announcements
Appendix 4C and Quarterly Report for Mar 2026 Quarter
Wellnex Life achieved a significant milestone by returning to positive operating cash flow of $0.41M in Q3 FY26, marking the first profitable quarter since its turnaround strategy commenced. Customer cash receipts surged 30.8% to $6.67M driven by strong commercial momentum across core brands, though reported revenue declined 28.2% to $5.1M due to cyclical IP licensing weakness and reduced marketing investment. The company demonstrated disciplined cost management with staff costs down 29% and is targeting revenue growth and margin improvement in Q4 FY26. Key points: First quarter of positive operating cash flow ($0.41M) since turnaround strategy commenced, validating management's strategic execution; Customer cash receipts surged 30.8% to $6.67M reflecting strong commercial momentum across core brands (Pain Away, Wakey Wakey, Nighty Night) and improved working capital conversion; Structural cost reductions delivering measurable results: staff costs down 29% to $0.75M and advertising/marketing down to $0.54M, demonstrating broad-based operational efficiency
Ceasing to be a substantial holder
UBS Group AG ceased to be a substantial holder.
Get real-time alerts for WNX
Receive AI-powered earnings summaries and instant notifications when Wellnex Life Limited releases results.
Register Free